MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Linac-Based MRI-Guided Radiation Therapy System Awarded CE Mark

By MedImaging International staff writers
Posted on 26 Sep 2016
Print article
Image: The MRIdian is intended for imaging and treating cancer patients in real-time (Photo courtesy of ViewRay).
Image: The MRIdian is intended for imaging and treating cancer patients in real-time (Photo courtesy of ViewRay).
The manufacturer of a next-generation linear accelerator, the only clinical MRI-guided radiation therapy system in the world, has announced that they have received CE (Conformité Européenne) mark approval for their new product.

The Magnetic Resonance Imaging (MRI)-guided radiation therapy system facilitates radiation therapy treatments, by providing MRI alignment, and real-time MRI tracking. The system provides pre-treatment images and soft-tissue imaging during radiation therapy treatment to enable clinicians to see and follow the tumor target, and radiation delivery, sparing healthy tissue. The system includes built-in treatment planning software, and advanced tools for contouring.

ViewRay (Cleveland OH, USA) developed the MRIdian system and has also submitted an application for 510(k) approval of the technology by the US Food and Drug Administration (FDA). The MRIdian is now available for clinical use in Europe, and for use in non-clinical research in the US.

The MRIdian system enables clinicians to observe, assess, and personalize treatments while the radiotherapy beam is on. This enables them to see the target and observe where the radiation is actually being delivered, and adapt to changes in the patient’s anatomy.

President and CEO of ViewRay, Chris A. Raanes, said, "We are excited to have CE Mark approval and to begin selling MRIdian Linac within Europe. We believe the radiation oncology community has been eagerly awaiting the availability of a clinical MRI-guided Linac system, and we're pleased to bring them ViewRay's well-established MRI-guidance capabilities with the familiar functionality of a linac-based platform. We now look forward to progress on our 510(k) filing with the FDA."

Related Links:
ViewRay

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound Needle Guide
Ultra-Pro II
Ultrasound System
Acclarix AX9
Brachytherapy Planning System
Oncentra Brachy

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)

New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients

Clear cell renal cell cancer (ccRCC) represents 70-80% of renal cell carcinoma cases. While localized disease can be effectively treated with surgery and ablative therapies, one-third of patients either... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more